INDP
Indaptus Therapeutics Inc
Stock NASDAQ – Stock Market Prices, News & Analysis
Biopharmaceutical company specializing in the development of advanced therapies in immunology and oncology.
Indaptus Therapeutics Inc
INDP
Biopharmaceutical company specializing in the development of advanced therapies in immunology and oncology.
Price history of Indaptus Therapeutics Inc
Price history of Indaptus Therapeutics Inc
Performance & Momentum
Strategic Analysis
Indaptus Therapeutics Inc • 2026
Indaptus Therapeutics is a U.S. biopharmaceutical company focused on innovative immunotherapies for oncology, aiming to leverage advanced immunology approaches to treat difficult-to-treat cancers. Its business model is based on the clinical development of differentiated drug candidates in a highly competitive and risky sector.
- Positioning in immuno-oncology therapies, a fast-growing segment with strong therapeutic potential.
- Technological expertise in innovative immunomodulation-based treatments.
- Long-term valuation upside if the clinical programs deliver positive results.
- Very weak stock performance over the medium and long term, undermining investor confidence.
- Lack of recent news supporting a turnaround or near-term catalyst.
Momentum is currently neutral to weak, with a pronounced downtrend over several years, reflecting a difficult financial and operating environment. This dynamic calls for extreme caution and is suited only to risk-tolerant investors waiting for a meaningful clinical development or a strategic shift in direction.
Similar stocks to Indaptus Therapeutics Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
